SynthesisCardiovascular drugs and therapy2021

Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial.

Philip Sarajlic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.